ALFA Filings
Every announcement, straight from the exchange
Every Prism Medico and Pharmacy other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
7 announcements
Prism Medico and Pharmacy Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31. This is a routine filing.
Prism Medico and Pharmacy Limited has informed that no interest, dividend, or principal is payable on non-convertible securities for the quarter ending December 31, 2026.
Prism Medico and Pharmacy Limited has submitted an undertaking confirming its website is updated and functional in compliance with SEBI Regulation 46.
Prism Medico and Pharmacy Ltd filed its investor complaints report for the quarter ended June 30, 2026. No complaints were received or pending.
Prism Medico and Pharmacy Limited confirmed it is not classified as a 'large corporate entity' as of March 31, 2026. Consequently, the SEBI mandated debt disclosure framework for large corporates is not applicable to the company.
Prism Medico and Pharmacy Limited reported nil investor complaints for the quarter ended March 31, 2026. All categories, including pending, received, and disposed complaints, remained at zero. The filing complies with Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Prism Medico and Pharmacy Ltd's promoters have confirmed that no shares held by them were encumbered or pledged during the financial year ended March 31, 2026. This annual disclosure under SEBI SAST Regulations reinforces transparency regarding promoter shareholding and the absence of new liens on their equity stake.